| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.01 |